Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Support

This activity is supported by educational grants from Janssen Scientific Affairs, LLC; Pharmacyclics LLC, an AbbVie Company; and Seagen Inc.

Mentors in Medicine Series on Applied Precision Medicine: Focus on Sequencing Treatment Care in CLL

Release Date: April 29, 2021
Expiration Date: April 29, 2022

Activity Overview

This online, on-demand, case-based, CME-certified webcast brings together renowned experts in the treatment of chronic lymphocytic leukemia (CLL). It provides guidance for practicing oncologists on how to incorporate biomarker testing into everyday clinical practice to determine diagnosis and inform treatment selection for their patients with CLL. The panel analyzes recent clinical trial evidence to optimize therapeutic strategies, using real patient cases as a starting point. Each case includes an expert analysis of Show Me the Data® as well as Key Takeaways 4 Tomorrow that can be applied immediately in the oncology clinical practice.

This educational activity is an archive of the live virtual webcast held on April 22, 2021.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Janssen Scientific Affairs, LLC; Pharmacyclics LLC, an AbbVie Company; and Seagen Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational program is intended for medical oncologists involved in the treatment of patients with chronic lymphocytic leukemia (CLL). Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of CLL are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Incorporate biomarker testing into diagnosis and/or therapy selection for treatment of patients with CLL
  • Analyze recent data on the efficacy and safety of therapeutic options for the treatment of patients with CLL
  • Apply optimal management strategies in the treatment of patients with CLL based on recent clinical trial findings

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.

Series Chair

Andre Goy, MD
Andre Goy, MD
Physician-in-Chief, Hackensack Meridian Health Oncology Care Transformation Service
Chairman & Chief Physician Officer, John Theurer Cancer Center
Lydia Pfund Chair for Lymphoma
Academic Chairman Oncology, Hackensack Meridian School of Medicine
Professor of Medicine, Georgetown University
Hackensack, NJ

Disclosures: Grant/Research Support: PI: Acerta Pharma, AstraZeneca, Celgene Corp, Constellation Pharmaceuticals, Genentech/Hoffmann-La Roche, Infinity Pharmaceuticals, Infinity Pharmaceuticals/Verastem Oncology, Janssen Pharmaceuticals, Karyopharm Therapeutics, Kite Pharma, Pharmacyclics; Consultant: Acerta Pharma, Celgene Corp, Gilead Sciences, Janssen Pharmaceuticals, Kite Pharma, Xcenda; Stock/Shareholder: COTA; Other: Honoraria: AstraZeneca, Celgene Corp, Gilead Sciences, Kite Pharma, Xcenda; Advisory: AstraZeneca, COTA, Elsevier’s PracticeUpdate, Gilead Sciences, Janssen Pharmaceuticals, Kite Pharma.

Moderator

Lori A. Leslie, MD
Lori A. Leslie, MD
Director, CLL and iNHL Programs
Lymphoma Division
John Theurer Cancer Center
Hackensack University Medical Center
Assistant Professor of Medicine
Hackensack Meridian Health School of Medicine
Hackensack, NJ
Medical Co-Director of Oncology
Mountainside Medical Center
Montclair, NJ

Disclosures: Consultant: ADC Therapeutics, BeiGene, Epizyme, Janssen Pharmaceuticals, Kite Pharma, Pharmacyclics, TG Therapeutics; Speaker’s Bureau: AstraZeneca, BeiGene, Celgene/Bristol Myers Squibb, Epizyme, Janssen/Johnson & Johnson, Karyopharm Therapeutics, Kite Pharma, Pharmacyclics, Seagen, TG Therapeutics.

Faculty

Jacqueline Barrientos, MD, MS
Jacqueline Barrientos, MD, MS
Associate Professor
Department of Medicine
Donald and Barbara Zucker School of Medicine
Hofstra/Northwell
New Hyde Park, NY

Disclosures: Grant/Research Support: AbbVie, Oncternal Therapeutics, VelosBio; Consultant: AbbVie, BeiGene, Janssen Pharmaceuticals.

Alessandra Ferrajoli, MD
Alessandra Ferrajoli, MD
Professor
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Disclosures: Grant/Research Support: AstraZeneca, BeiGene, Janssen Pharmaceuticals.

Anthony Mato, MD, MSCE
Anthony Mato, MD, MSCE
Director, CLL Program
Associate Professor of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures: Grant/Research Support: AbbVie, AstraZeneca, Genentech, Janssen Pharmaceuticals, Loxo Oncology, TG Therapeutics.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By